1-hexadecanoyl-2--(5Z,8Z,11Z,14Z-eicosatetraenoyl)-<I>sn</I>-glycero-3-phospho-(1′<I>rac</I>glycerol) (sodium salt); PAPG; PG(16:0/20:4(5Z,8Z,11Z,14Z)); 110651

产品名称：

322647-47-2
16:0-20:4 PG
1-hexadecanoyl-2--(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PAPG; PG(16:0/20:4(5Z,8Z,11Z,14Z)); 110651

产品介绍：

产品说明

一般描述

16:0-20:4 PG or 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-(1′-rac-glycerol) is a sodium salt of glycerophospholipid, with substitution of palmitic acid, arachidonic acid and phospho-rac-(1-glycerol) at the sn-1, sn-2 and sn-3 positions respectively, in the glycerol backbone.

应用

16:0-20:4 PG or 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt) has been used in liposomes to study its effect on the proliferation of mouse keratinocytes, in vitro.

包装

5 mL Clear Glass Sealed Ampule (840499C-25mg)

基本信息

经验(实验)分子式	C₄₂H₇₄O₁₀PNa
分子量	792.99
NACRES	NA.25

产品性质

测定	>99% (TLC)
包装	pkg of 1 × 2.5 mL (840499C-25mg)
manufacturer/tradename	Avanti Polar Lipids 840499C
浓度	10 mg/mL (840499C-25mg)
运输	dry ice
储存温度	−20℃

安全信息

象形图
警示用语：	Danger
危险声明	H302 - H315 - H319 - H331 - H336 - H351 - H361d - H372
预防措施声明	P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
危险分类	Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
靶器官	Central nervous system
储存分类代码	6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
WGK	WGK 3
闪点(F)	does not flash
闪点(C)	does not flash